Next-generation sequencing with Mirna Jarosz
In this BioTechniques behind the technique, we met Mirna Jarosz – Director of Next-Generation Sequencing (NGS) Business Development at Integrated DNA Technologies (IDT; IA, USA) – at AACR 2019 to discuss the impact NGS is having on cancer research, the best NGS technology innovations, the importance of collaborations and the future of NGS.
You can find out more about NGS technologies here.
Submit Your Research to the F1000Research Oncology Gateway
Share your oncology research with the global scientific community through the F1000Research Oncology Gateway. With trusted publishing, open access, and transparent peer review, your work will uphold the highest standards of research integrity while driving innovation in cancer treatment and understanding.
Join a trusted platform that accelerates progress in oncology. Submit your research today at F1000Research Oncology Gateway.
